Leg Ischaemia Management Collaboration

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorUniversity of Leicester

About this trial

Single-centre prospective cohort study of patients presenting with severe limb ischaemia (SLI). The primary outcome measure will be 12 month major amputation rate. A historical cohort of patients identified retrospectively will be the comparitor group used to assess the impact of a newly-established rapid-access limb salvage clinic.

Primary aim:

\- Determine the proportion of patients with SLI undergoing major lower limb amputation within 12 months of presentation.

Secondary aims:

* Assess clinically important short-, medium- and long-term outcomes in those undergoing and not undergoing amputation * Prevalence and degree of frailty and cognitive impairment * Pevalence and degree of cardiac disease (detected by stress MRI) * Establish a biobank for future biomarker analysis * Investigate the role of frailty and cognitive assessments, cardiac MRI and biomarkers in risk-stratification of patients with SLI

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients presenting to the Leicester Vascular Institute with SLI

Disqualifiers

SLI not caused by PAOD

Patients undergoing intervention during their index presentation prior to recruitment

Patients lacking capacity to consent with no accompanying next of kin, relative, partner or friend who can act as a personal consulted

Patients who cannot read, write or understand English

Trial population

As representative a sample of patients presenting to the Leicester Vascular Institute with SLI during the study period as possible. All patients presenting with SLI within the age criteria will be eligible and personal consultee consent will allow recruitment even of those patients lacking capacity to consent.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

420 Participants
are grouped into 5 trial groups
Group A: Primary cohort
Group B: Frailty & cognitive additional assessments
Group C: Cardiac MRI additional assessments
Group D: Biomarkers additional assessments
Group E: Historical cohort

Trial outcomes

Primary outcomes

1

12 month amputation rate

Proportion of patients undergoing major lower limb amputation

Time frame
12 months post recruitment

Secondary outcomes

1

Amputation free survival

Composite outcome measure of death or amputation

Time frame
≥12 months post recruitment
2

All-cause mortality

Death from any cause

Time frame
≥12 months
3

Quality of life

Quality of life as measured by the Vascular Quality of Life questionnaire (VascuQoL) * 25 item questionnaire, score 1-7 for each item, higher score = better quality of life * Domains: activities (8 items), symptoms (4 items), pain (4 items), social (2 items) and emotional (7 items); each scored 1-7 (total of domain item scores/number of items) * Overall score 1-7 (total item score/25)

Time frame
12 and 24 months post recruitment
4

Disability

Level of disability as measured by the Barthel Index \- Score 0-20; higher score = greater degree of functional independence/lower level of disability

Time frame
12 and 24 months post recruitment

Other outcomes

1

Cognitive impairment (Frailty & Cognitive additional assessments only)

Prevalence of cognitive impairment as detected by the Montreal Cognitive Assessment (MoCA) * Score 0-30; highger score = greater level of cognitive function * Results will also be reported dichotomised to normal (score ≥24) and cognitive impairment (score ≤23)

Time frame
Baseline, 3 and 12 months
2

Post-operative delirium (Frailty & Cognitive additional assessments only)

Incidence of post-operative delirium as detected by the Single Question in Delirium (SQiD) +/- 4 A's Test for delirium (4AT)

Time frame
24 and 72 hours post intervention
3

Prevalence of coronary artery disease (Cardiac MR additional assessments only)

Prevalence of coronary artery disease as detected by stress cardiac MRI

Time frame
Baseline
4

Incidence of peri-operative myocardial infarction (Cardiac MR additional assessments only)

Incidence of peri-operative myocardial infarction as detected by cardiac MRI

Time frame
2-4 months post intervention

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Leicester

Lead sponsor

University Hospitals, Leicester

Collaborator

National Institute for Health Research, United Kingdom

Collaborator

The George Davies Charitable Trust

Collaborator